Lung Carcinoma
95
30
43
29
Key Insights
Highlights
Success Rate
83% trial completion
Published Results
11 trials with published results (12%)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
6.3%
6 terminated out of 95 trials
82.9%
-3.7% vs benchmark
1%
1 trials in Phase 3/4
38%
11 of 29 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 29 completed trials
Clinical Trials (95)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
A New Way to Share Radiation Therapy Plans Between Doctors, CORRECT Trial
Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal, Gynecological, Breast, or Lung Cancer
Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington State, SACRED LUNGS Trial
A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to Increase Lung Cancer Screening Among Black Community Members, RESTORE Trial
Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting
The Rise in Robotic Atypical Segmentectomies
HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics
Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool
The Vanguard Study: Testing a New Way to Screen for Cancer
Testing the SurVaxM Vaccine for Lung Cancer Prevention
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues
Home-Based Respiratory Muscle Training and Aerobic Exercise Programs to Improve Lung Health in Current and Former Cigarette Smokers
Patient-Derived Xenografts to Reduce Cancer Health Disparities
Continuous Positive Airway Pressure Device or Deep Inspiration Breath Hold in Reducing Tumor Motion in Patients Undergoing Stereotactic Body Radiation Therapy for Lung Cancer
Risk and Benefits of Electronic Cigarettes to Older Smokers at High Risk for Lung Cancer
MUC1 Vaccine in Preventing Lung Cancer in Current and Former Smokers at High Risk for Lung Cancer